(±)-MMT5-14 is used for research on COVID-19 due to its higher antiviral activity against four SARS-CoV-2 variants compared to Remdesivir; it inhibits SARS-CoV-2 and its α, β, γ, and δ variants with EC50 values of 0.4, 2.5, 15.9, 1.7, and 5.6 μM, respectively.